Akebia Therapeutics reported $-59544000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Akebia Therapeutics AKBA:US $ -59.54M 23.49M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Ardelyx ARDX:US $ 43.59M 88.77M
Astellas Pharma 4503:JP Y 53255M 17425M
AstraZeneca AZN:LN 1954M 415M
Exelixis EXEL:US $ 53.26M 71.63M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -84M 3M
Johnson & Johnson JNJ:US $ 8058M 282M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Moderna Inc MRNA:US 3.55B 489M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Opko Health OPK:US $ 31.47M 31.74M
Prothena PRTA:US $ 109.2M 81.3M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Vanda Pharmaceuticals VNDA:US $ 10.72M 1.88M